Domingo Rodriguez M.D. has served as Executive Vice President of Clinical Operations since April 2018.
Prior to joining Veru, Dr. Rodriguez was the Vice President of Global Development Operations at Mallinckrodt Pharmaceuticals from 2013 to April 2018 where he was a member of the Science and Technology Senior Management Team with his main responsibility being the clinical trial execution of all clinical-stage programs and indications both in the U.S. and abroad.
From 2004 to 2013, Dr. Rodriguez served in various positions at GTx, Inc., including Vice President of Clinical Operations.
Dr. Rodriguez brings more than 30 years of biotechnology, pharmaceutical and device experience to Veru Inc. in small, mid-size and large companies with expertise in Clinical Development, Medical Affairs, Due Diligence, Acquisitions, Integrations, FDA Inspections and Sales and Marketing.
Dr. Rodriguez has conducted global clinical development that includes oncology, male health and autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology, regenerative medicine, immunotherapy and neonatal respiratory critical care therapies, transplants, analgesics, pediatrics, orphan/rare diseases and devices.
Dr. Rodriguez completed medical school at CETEC University in the Dominican Republic.